You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 8, August 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Topical Ciprofloxacin for Otorrhea After Tympanostomy Tube Placement

Rex W. Force, PharmD; Mary C. Hart, MD; Sally A. Plummer, PhD; Dwight A. Powell, MD; Milap C. Nahata, PharmD

Arch Otolaryngol Head Neck Surg. 1995;121(8):880-884.


Abstract

Objective
To evaluate the efficacy, systemic absorption, and safety of ototopically administered ciprofloxacin in children with otorrhea associated with tympanostomy tube placement.

Design
Nonrandomized, open-label pilot trial with pharmacokinetic determination of the systemic absorption of ototopical ciprofloxacin.

Setting
A pediatric otolaryngology clinic affiliated with Columbus (Ohio) Children's Hospital.

Patients
Patients aged 3 to 8 years were enrolled if they had persistent otorrhea associated with tympanostomy tube placement. Other inclusion criteria were culture of Pseudomonas aeruginosa from the drainage material; failure of previous oral antibiotic therapy; and ability to participate in bone conduction audiometry.

Intervention
Participants received 3 drops (approximately 60 µL) of 0.3% ototopical ciprofloxacin hydrochloride (Ciloxan, Alcon Laboratories Inc, Forth Worth, Tex), three times a day, for 14 days. Bone conduction audiometry was performed at baseline and on day 14. Patients were examined on days 7 and 14 for efficacy of treatment (improvement, cure, failure) and adverse effects. On day 7, blood samples were drawn just before and 1 hour after the dose was given. Concentrations of ciprofloxacin were measured by high-performance liquid chromatography, with a 5 ng/mL limit of detection. Telephone follow-up was performed on day 44. Parents were asked about adverse effects at days 7, 14, and 44.

Results
Mean duration of ear drainage at baseline was 10.7 months (0.75 to 36 months). Ten of 11 infected ears (nine of 10 patients) were improved or cured at day 7. Ten of 11 ears were completely cured at days 14 and 44. No adverse effects were noted or reported by the children's parents. One child had abnormal bone conduction audiometry results at baseline. The results of bone conduction audiometry on day 14 were normal in all children. Trough concentrations of ciprofloxacin were determined in eight of 10 children; and peak concentrations were determined in seven of 10 children. Ciprofloxacin was not detected in the plasma of any child.

Conclusion
Topical ciprofloxacin was found to be safe and effective in treating otorrhea in children who did not respond to other treatments.

(Arch Otolaryngol Head Neck Surg. 1995;121:880-884)



Author Affiliations

From the Colleges of Pharmacy (Drs Force and Nahata) and Medicine (Dr Hart), The Ohio State University, the Wexner Institute for Pediatric Research (Drs Force, Powell, and Nahata), and the Department of Speech Pathology and Audiology, Children's Hospital (Dr Plummer), Columbus, Ohio. Dr Force is now with the College of Pharmacy and Department of Family Medicine, Idaho State University, Pocatello.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antibacterial Effect of Octylcyanoacrylate against Ciprofloxacin-resistant Pseudomonas aeruginosa Isolates from Patients with Chronic Suppurative Otitis Media
JANG et al.
In Vivo 2009;23:183-185.
ABSTRACT | FULL TEXT  

Topical Ciprofloxacin/Dexamethasone Otic Suspension Is Superior to Ofloxacin Otic Solution in the Treatment of Children With Acute Otitis Media With Otorrhea Through Tympanostomy Tubes
Roland et al.
Pediatrics 2004;113:e40-46.
ABSTRACT | FULL TEXT  

Follow-up Management of Children with Tympanostomy Tubes
Section on Otolaryngology and Bronchoesophagology
Pediatrics 2002;109:328-329.
ABSTRACT | FULL TEXT  

Methicillin-Resistant Staphylococcus aureus Otorrhea After Tympanostomy Tube Placement: An Emerging Concern
Hartnick et al.
Arch Otolaryngol Head Neck Surg 2000;126:1440-1443.
ABSTRACT | FULL TEXT  

Topical Ofloxacin Treatment of Otorrhea in Children With Tympanostomy Tubes
Dohar et al.
Arch Otolaryngol Head Neck Surg 1999;125:537-545.
ABSTRACT | FULL TEXT  

Chronic Otitis Media Treated Topically With Ciprofloxacin or Tobramycin
Milo et al.
Arch Otolaryngol Head Neck Surg 1997;123:1057-1060.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.